Praxis Precision Medicines, Inc. PRAX Enterprise value

Enterprise value at other companies

Jazz PharmaceuticalsJAZZ

$16.37B+47.7%

Xenon PharmaceuticalsXENE

$5.72B+144%

Stoke Therapeutics, Inc.STOK

$1.77B+1,855%

Rapport Therapeutics, Inc.RAPP

$1.94B+375%

Neurocrine BiosciencesNBIX

$13.41B+18.5%

BiogenBIIB

$38.17B+70.8%

FAQ

What is Praxis Precision Medicines, Inc.'s enterprise value?

Praxis Precision Medicines, Inc. (PRAX) reported enterprise value of $8.86B in Q2 2026.

How has Praxis Precision Medicines, Inc.'s enterprise value changed year-over-year?

Praxis Precision Medicines, Inc.'s enterprise value increased by 1100.0% year-over-year, from $738.34M to $8.86B.

What is the long-term trend for Praxis Precision Medicines, Inc.'s enterprise value?

Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s enterprise value has grown at a 26.4% compound annual growth rate (CAGR), from $2.17B to $7.01B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.